PRCT: Procept BioRobotics Corp Company Profile & Statistics

About

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif.

Info & Links

CEO

Reza Zadno

Headquarters

150 Baytech Drive
San Jose, CA 95134, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

626

Procept BioRobotics Corp Statistics

Valuation Measures

Market Capitalization²

4.27B

Enterprise Value

4.13B

Enterprise Value/EBITDA(ttm)

-40.75

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

23.30

Price to Book(mrq)

19.31

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

56.81%

Operating Margin(ttm)

-50.07%

Profit Margin(ttm)

-51.34%

Return on Equity(ttm)

-38.57%

Return on Invested Capital(ttm)

-32.13%

Return on Assets(ttm)

-26.06%

Income Statement

Revenue(ttm)

199.84M

Revenue Per Share(ttm)

3.83

Gross Profit(ttm)

114.68M

EBITDA(ttm)³

-101.36M

Net Income Available to Common(ttm)

-100.06M

Diluted EPS(ttm)

-1.95

Share Statistics

Beta (5Y Monthly)

0.99

52-Week Change

115.38%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

52.18M

Dividend Yield

0.00%

Float⁴

43.10M

% Held by Insiders

17.40%

% Held by Institutions

89.46%

Balance Sheet

Total Cash(mrq)

196.76M

Total Cash Per Share(mrq)

3.77

Total Debt(mrq)

53.44M

Total Debt/Equity(mrq)

22.15%

Current Ratio(mrq)

6.02%

Quick Ratio(mrq)

5.07%

Book Value Per Share(mrq)

4.63

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.28

Free Cash Flow(ytd)

-70.06M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PRCT

Procept BioRobotics Corp

Procept BioRobotics Corp Profile